Platform Therapeutics Explained
Richard discusses the unique approach of investing in platform therapeutics, emphasizing the importance of having multiple targets for drug discovery. This strategy allows for more opportunities to succeed in clinical trials, even if individual projects fail. The conversation also touches on investments in bioindustrials and agriculture, highlighting the innovative use of engineered biology in these fields.In this clip
From this podcast
The Hard Part with Evan McCann
Richard Waines from DCVC Bio
Related Questions
As a VC investor, when I see that each feature within a startup platform can become a company (or can spin out to this feature), is it one of the signs that the company can be big? What do you think about this in the context of the episode Recipe: Startup Innovation with Erick Hachenburg and the clip Innovation Strategies?
As a VC investor, when I see that each feature within a startup platform can become a company (or can spin out to this feature), is it one of the signs that the company can be big? What do you think about this in the context of the episode Recipe: Startup Innovation with Erick Hachenburg and the clip Innovation at Google?